info@labtron.com
| Technology | Sequencing-by-synthesis technology |
| Medium Throughput Chip Reads | 60 M |
| High Throughput Chip Reads | 170 M |
| CPU | Main frequency above 2.3 GHz |
| Memory | 128 GB or more |
| Solid State Drive | 480 GB + 4 TB |
| Monitor | Resolution of 1920 × 1080 or higher |
| Operating System | Compatible with Windows 10 or later versions |
| Air Pressure | 700 hPa to 1060 hPa |
| Altitude | Not exceeding 3000 m |
| Permissible Temperature | 19°C to 25°C |
| Permissible Humidity (RH) | 10% to 85% (Non-condensing) |
| Frequency | 50Hz ± 1Hz |
| Power | 750 VA |
| Input Voltage | AC 220V ± 22V |
| Dimensions | 825 × 687 × 788 mm |
| Weight | 120 kg |
Offers 2 chip configuration
Refined optical detection system
Time-sensitive diagnostics
High-precision data
Compact and durable design
Our Next Generation Sequencer LNGS-A10 is ideal for applications such as non-invasive prenatal testing (NIPT), targeted sequencing, and infectious disease detection. It also supports low-pass whole genome sequencing, forensic analysis, and environmental DNA studies.
Chip Type | Reads | Read Length | Throughput | Data Quality | Sequencing Time |
Medium Throughput | 60 M | 50 bp | 3 G | Q30 is greater than 90% | Up to 3.5 hours |
Medium Throughput | 60 M | 75 bp | 4 G | Q30 is greater than 90% | Up to 5 hours |
Medium Throughput | 60 M | 300 bp | 18 G | Q30 is greater than 90% | Up to 22 hours |
High Throughput | 170 M | 50 bp | 8 G | Q30 is greater than 85% | Up to 4.5 hours |
High Throughput | 170 M | 75 bp | 12 G | Q30 is greater than 90% | Up to 6 hours |
High Throughput | 170 M | 300 bp | 50 G | Q30 is greater than 85% | Up to 24 hours |
Methods | Applications | Data Volume/ Sample | Read Length | 60 M Samples/Run | 170 M Samples/Run |
Low-pass Whole Genome Sequencing | NIPT | ~ 5 M reads | SE 50 | 12 | 34 |
Low-pass Whole Genome Sequencing | Targeted Pathogen Sequencing (tNGS) | 0.5 M to 1 M reads | SE 50 | 60 to 120 | 170 to 340 |
Low-pass Whole Genome Sequencing | Small Panel for Tumor Companion Diagnostics | ~ 1 Gb | PE 150 | 18 | 51 |
Targeted Sequencing | Small Panel for Genetic Diseases (Deafness, Metabolism) | 3 to 5 Gb | PE 150 | 3.6 to 6 | 10.2 to 17 |
Targeted Sequencing | 16S Sequencing | ~ 0.5 M reads | PE 300 | 60 | 170 |
Targeted Sequencing | Forensic DNA Identification | ~ 0.5 M reads | SE 400 | 120 | 340 |
Small Genome Sequencing | Bacterial / Virus | ~ 1 Gb | PE 150 | 18 | 51 |
Methylation Sequencing | Pan-cancer Early Screening | ~ 1 Gb | PE 150 | 18 | 51 |
Download catalog for
Next Generation Sequencer LNGS-A10 Catalog
Labtron’s Next Generation Sequencers offer fast and accurate genomic data, making them ideal for advanced research applications. They are designed with scalability in mind, catering to both small laboratories and high-throughput research facilities. These sequencers feature intuitive software integration that streamlines complex workflows and simplifies data analysis. With reliable performance and consistent results, they support a wide range of genomic applications. Our sequencers are well-suited for clinical, academic, and pharmaceutical research environments.
Labtron’s Next Generation Sequencer uses sequencing-by-synthesis (SBS) technology, a proven and widely adopted method in the genomics field. This technique involves the incorporation of fluorescently labeled nucleotides during DNA strand synthesis. The sequencer detects these signals using a refined optical system to determine the DNA sequence. SBS is recognized for its accuracy, scalability, and suitability for diverse applications ranging from clinical diagnostics to complex genetic research.
Our Next Generation Sequencer supports both medium and high throughput chip configurations. Medium throughput offers 60 million reads with throughput between 3 G and 18 G and sequencing times from 3.5 to 22 hours. High throughput chips provide 170 million reads with throughput from 8 G to 50 G, with sequencing times ranging from 4.5 to 24 hours. The system is optimized to produce results as fast as 3.2 hours depending on the setup and application.
This Next Generation Sequencer ensures data accuracy through a refined optical detection system and the SBS sequencing method. It achieves Q30 scores greater than 85% to 90%, indicating that the probability of incorrect base calls is extremely low. This high data quality is critical for applications requiring precise genomic information, such as clinical diagnostics and genetic analysis.
Yes, the Next Generation Sequencer is specifically built for time-sensitive scenarios. It can generate sequencing results in as little as 3.2 hours, making it suitable for rapid diagnostics in clinical settings such as prenatal testing, infectious disease identification, and oncology. Its streamlined workflow and fast turnaround enhance decision-making in critical timeframes.
Yes, the Next Generation Sequencer is designed for scalability. It supports both medium and high throughput chip options, allowing labs to increase sequencing capacity without replacing equipment. This flexibility ensures that users can adapt to growing project demands or research expansion, making it a cost-effective long-term investment for clinical and research facilities.
Post your question?
Our experts are here to help!
Labtron Equipment Ltd., Quatro House, Lyon Way, Camberley, Surrey GU16 7ER United Kingdom
Email: info@labtron.com Whatsapp: +44 73 4441 2688 Phone: +44 2080 043608